The global pharma market is expected to reach USD 1.5 trillion by next year. The industry is also expected to have a compound annual growth rate between 3 and 6 percent in the next five years. The global specialty pharmaceuticals market size is al...
Relief Therapeutics Holding SA, a Swiss, commercial-stage biopharmaceutical company, announced that it has hired a leading national health services company to serve as exclusive distributor of PKU Golike in the US....
Glenmark Pharmaceuticals Limited has become the first to launch Thiazolidinedione Lobeglitazone in India for the treatment of type 2 diabetes in adults. Marketed under the brand name LOBG, it contains lobeglitazone (0.5 mg) and is to be taken once...
A Japanese health ministry panel recommended approving Pfizer Inc's COVID-19 vaccine for children as young as six months old....
Swedish geneticist Svantee Paabo, whose work provided key insights into human evolution and and how humans spread around the planet by achieving "the seemingly impossible task" of cracking the genetic code of the Neanderthals was Monday announced...
Zydus Lifesciences said it has received the USFDA's final nod to market its generic version of Mirabegron extended-release tablets used to treat overactive bladder, with 180 days of shared generic drug exclusivity. The final approval granted by...
The Department-related Parliamentary Standing Committee on health and family welfare has recommended to the Central government to look at regulating the price of services such as radio therapy, under the provisions of the Essential Commodities Act...
The new pharma health trends and the use of latest technologies such as Artificial Intelligence, Augmented Reality, additive manufacturing & Virtual Reality, are indications of a significant paradigm shift in the healthcare industry.
Amylyx Pharmaceuticals Inc said the U.S. Food and Drug Administration approved its drug for slowing the progression of ALS, or amyotrophic lateral sclerosis, and potentially delaying death, sending shares of the company up nearly 14% in extended...
Drug maker Lupin said it has launched Sildenafil for Oral Suspension, indicated for the treatment of pulmonary arterial hypertension, in the US market. The firm said it has introduced the product after getting approval from the US Food...
.jpg)
, CDSCO.jpg "Fostering a Quality Culture in the Pharmaceutical Industry")